Back to top
more

Avita Medical (RCEL)

(Delayed Data from NSDQ)

$10.55 USD

10.55
86,161

-0.17 (-1.59%)

Updated Oct 1, 2024 04:00 PM ET

After-Market: $10.57 +0.02 (0.19%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 252)

Industry: Medical - Drugs

Better trading starts here.

Zacks News

Does Avita Medical Inc. (RCEL) Have the Potential to Rally 210% as Wall Street Analysts Expect?

The mean of analysts' price targets for Avita Medical Inc. (RCEL) points to a 209.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

AVITA Medical, Inc. (RCEL) Soars 8%: Is Further Upside Left in the Stock?

AVITA Medical, Inc. (RCEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Acadia Healthcare (ACHC) Starts Building New Behavioral Facility

Acadia Healthcare (ACHC) opens a new behavioral facility to tap the growing market of mental illness.

All You Need to Know About AVITA Medical, Inc. (RCEL) Rating Upgrade to Buy

AVITA Medical, Inc. (RCEL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Acadia Healthcare (ACHC) Forms JV to Build Behavioral Health Units

Acadia Healthcare (ACHC) enters into a joint venture with Geisinger Health to build twin units for offering access to the much-needed behavioral healthcare all across Pennsylvania.

Acadia Healthcare (ACHC) Gets Rating Upgrade Post U.K. Unit Sale

Acadia Healthcare's (ACHC) numerous ratings get upgraded by Moody's after the divestment of its U.K. operations.

AVITA Medical (RCEL) is Overbought: Is A Drop Coming?

AVITA Medical, Inc. (RCEL) has moved higher as of late, but there could definitely be trouble on the horizon for this company.

Acadia Healthcare (ACHC) to Sell UK Unit to Focus on US Business

Acadia Healthcare (ACHC) to divest its U.K. business to Waterland for concentrating on its mental health business in the United States.

Acadia Healthcare (ACHC) Up 54% in 6 Months: More Room to Run?

Acadia Healthcare (ACHC) gains on the back of rising demand for its behavioral healthcare services, business rejig, cost-controlling efforts and strong cash flows.

Reasons to Add Acadia Healthcare (ACHC) to Your Portfolio

Better-than-expected Q3 results, positive estimate revisions, high demand for services, bed expansion, business streamlining make Acadia Healthcare (ACHC) an attractive investment bet.

Sanghamitra Saha headshot

4 Sector ETFs & Stocks to Buy on Forecast-Beating Jobs Data

The U.S. economy added 1.76 million jobs in July 2020, down from a record 4.8 million in the previous month. However, the reading beat market expectations of a 1.6 million increase.

Encompass Health to Build Rehabilitation Hospital in Illinois

Encompass Health (EHC) plans to build a rehabilitation facility in Illinois to serve the local community. The healthcare home will be launched in 2022 spring and complement other units in the area.

Sapna Bagaria headshot

Hospital Industry's Dull Near-Term Outllook Induced by Coronavirus

Revenue loss and cost rise due to coronavirus outbreak put hospital companies in a tight spot.

Community Health Systems (CYH) in Focus: Stock Moves 5.9% Higher

Community Health Systems (CYH) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Sanghamitra Saha headshot

Biotech Rally Sends Nasdaq to 9000: ETFs in Focus

Some biotech stocks have contributed materially to the Nasdaq's 1000-point gain since Aug 27, 2018 and helped it notch a record 9,000 on Dec 26.

Sanghamitra Saha headshot

5 Top-Ranked ADRs That More Than Doubled the S&P 500 in 2019

Though international markets trailed the U.S. market in 2019, there are hidden gems that crushed the S&P 500 this year on stock-specific strength.